Creating a scale to measure cancer patients' willingness to join drug trials
Development and Reliability and Validity Evaluation of a Scale for Cancer Patients' Willingness to Voluntarily Participate in Drug Clinical Trials
This study is trying to create a tool to see how willing cancer patients are to join drug trials, which could help make it easier to recruit them in the future.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 20 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Trial ID | NCT06120335 on ClinicalTrials.gov |
What this trial studies
This observational study aims to develop a scale that assesses cancer patients' willingness to voluntarily participate in drug clinical trials. It will evaluate the reliability and validity of this scale by including tumor patients aged 18-80 who have undergone the informed consent process for drug trials. The study will gather data on whether these patients ultimately sign up for a clinical trial. The findings could help improve recruitment strategies for future clinical trials.
Who should consider this trial
Good fit: Ideal candidates for this study are cancer patients aged 18-80 who have a clear diagnosis and are willing to participate in the study.
Not a fit: Patients with unclear consciousness, those unable to understand or answer questions, and vulnerable populations such as minors or prisoners may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of factors influencing cancer patients' willingness to participate in clinical trials, potentially leading to improved recruitment and better trial outcomes.
How similar studies have performed: While the approach of developing a willingness scale is not widely tested, similar studies have shown that understanding patient perspectives can improve clinical trial participation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 18-80 years old (including boundary values). 2. Tumor patients with clear diagnosis. 3. Whether they finally sign the informed consent form of one drug clinical trial or not, and whether they are finally enrolled in one drug clinical trial or not, patients who have undergone the informed consent process of drug clinical trials conducted by clinicians can be enrolled in this study. 4. Volunteer to participate in this study and sign an informed consent form. Exclusion Criteria: 1. Patients with unclear consciousness. 2. Patients who are unable to correctly understand and answer questions. 3. Vulnerable subjects include: students and subordinates of researchers, military personnel, prisoners, patients with incurable diseases, patients in critical situations, those admitted to welfare institutions, homeless individuals, minors, and those who are unable to provide informed consent.
Where this trial is running
Guangzhou, Guangdong
- Sun Yat-sen Memorial Hospital — Guangzhou, Guangdong, China (Recruiting)
Study contacts
- Study coordinator: Caie Chen
- Email: chence3@mail2.sysu.edu.cn
- Phone: 18707657343
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.